Recovery & Repair
GHK-Cu
A naturally occurring copper-binding tripeptide studied extensively in skin and connective tissue research.
- Physician reviewed
- 503A pharmacy compounded
- Patient-specific prescription
Formats & pricing
- 50mg vial — reconstituted injectable$270
Pricing reflects the compounded preparation and physician review. Final therapy and dosing are determined only after your intake is reviewed.
Overview
What is GHK-Cu?
GHK-Cu is a copper complex of the tripeptide glycyl-L-histidyl-L-lysine, present in human plasma and known to decline with age. It has one of the longer research histories among peptides used in aesthetic and regenerative protocols.
Mechanism
How it works
Research has examined GHK-Cu's relationship with collagen and elastin synthesis, antioxidant activity, and the remodeling phase of wound healing, alongside its role as a copper carrier in tissue.
Wellness support
Potential wellness support areas
These areas are commonly discussed within wellness-focused protocols. They are educational statements, not medical claims or guarantees of outcome.
- Explored for skin firmness, tone, and texture
- Discussed within hair and scalp wellness protocols
- Potential support for wound and scar remodeling
- Studied for connective tissue quality
Administration
Format & dosing
Available as a subcutaneous injectable or a compounded topical preparation depending on your goal. Your physician selects the format at review.
Labs & monitoring
Labs, testing & monitoring
Your physician determines the final testing requirements for GHK-Cu after reviewing your intake. The panels below are what is commonly reviewed for this therapy — they are educational guidance, not a fixed requirement.
Bloodwork status
Provider Determines Testing
Commonly reviewed at baseline
- CBC
- Comprehensive metabolic panel (CMP)
- Serum copper if clinically relevant
Follow-up & monitoring
Skin and hair response is assessed visually at follow-up. Copper status is only checked when your physician sees a reason.
Who may not be a candidate
- Pregnancy or nursing
- Active malignancy without oncology clearance
- Known hypersensitivity to the preparation
- Wilson disease or other copper-handling disorders
Medication interactions
Your physician reviews all prescriptions, supplements, and over-the-counter medications during intake before anything is prescribed.
Safety
Safety & considerations
Not FDA-approved; compounded per prescription. Patients with copper metabolism disorders, including Wilson's disease, should not use this therapy.
Regulatory status: Compounded. Evidence level: Limited. Eligibility, dosing, laboratory requirements, and follow-up care are determined exclusively by a licensed physician after review of your history.
Related therapies
Recovery & Repair
BPC-157
Connective tissue repair, joint mobility, and gut healing support.
Provider Determines Testing
Recovery & Repair
TB-500
Systemic tissue repair, flexibility, and injury recovery support.
Provider Determines Testing
Recovery & Repair
BPC-157 / TB-500
Dual-action recovery stack for tissue repair and systemic healing.
Provider Determines Testing
Physician reviewed
Every protocol is approved by a licensed physician.
503A compounded
Prepared by licensed US compounding pharmacies.
Patient-specific Rx
Prescriptions are issued in your name only.
No membership
No concierge fee and no subscription to browse or begin.